Archive

A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.

Contributors: Cowen, Philip J; Godlewska, Beata R; Holder, Adele A; Macdonald, Orla; Sharpley, Ann L; Williams, Clare

Subjects: Bipolar Disorder, Hypomania, Mania